• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

诊断放射科医师的下腔静脉滤器评估和管理:包括下腔静脉滤器相关并发症和 PRESERVE 试验滤器的综合综述。

Inferior Vena Cava Filter Evaluation and Management for the Diagnostic Radiologist: A Comprehensive Review Including Inferior Vena Cava Filter-Related Complications and PRESERVE Trial Filters.

机构信息

Department of Radiology, Section of Vascular and Interventional Radiology, University of Chicago Medicine, Chicago, Illinois, USA.

Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, Illinois, USA.

出版信息

Can Assoc Radiol J. 2019 Nov;70(4):367-382. doi: 10.1016/j.carj.2019.06.003. Epub 2019 Sep 27.

DOI:10.1016/j.carj.2019.06.003
PMID:31570169
Abstract

Inferior vena cava filters are commonly encountered devices on diagnostic imaging that were highlighted in a 2010 Food and Drug Administration safety advisory regarding their complications from long-term implantation. The Predicting the Safety and Effectiveness of Inferior Vena Cava Filters (PRESERVE) trial is an ongoing after-market study investigating the safety and utility of commonly utilized filters in practice today. While most of these filters are safe, prompt recognition and management of any filter-associated complication is imperative to prevent or reduce the morbidity and mortality associated with them. This review is aimed at discussing the appropriate utilization and placement of inferior vena cava filters in addition to the recognition of filter-associated complications on cross-sectional imaging. An overview of the PRESRVE trial filters is also provided to understand each filter's propensity for specific complications.

摘要

下腔静脉滤器是诊断成像中常见的装置,在 2010 年食品和药物管理局关于其长期植入并发症的安全咨询中重点介绍了这些装置。正在进行的下腔静脉滤器预测安全性和有效性(PRESERVE)试验是一项针对目前临床常用滤器安全性和实用性的上市后研究。虽然大多数这些滤器是安全的,但及时识别和处理任何与滤器相关的并发症对于预防或减少与之相关的发病率和死亡率至关重要。这篇综述旨在讨论下腔静脉滤器的合理使用和放置,以及在横断面成像上识别滤器相关并发症。还提供了 PRESRVE 试验滤器的概述,以了解每种滤器发生特定并发症的倾向。

相似文献

1
Inferior Vena Cava Filter Evaluation and Management for the Diagnostic Radiologist: A Comprehensive Review Including Inferior Vena Cava Filter-Related Complications and PRESERVE Trial Filters.诊断放射科医师的下腔静脉滤器评估和管理:包括下腔静脉滤器相关并发症和 PRESERVE 试验滤器的综合综述。
Can Assoc Radiol J. 2019 Nov;70(4):367-382. doi: 10.1016/j.carj.2019.06.003. Epub 2019 Sep 27.
2
Excimer Laser Sheath-Assisted Retrieval of "Closed-Cell" Design Inferior Vena Cava Filters.准分子激光辅助回收“闭孔”设计下腔静脉滤器。
J Am Heart Assoc. 2020 Sep;9(17):e017240. doi: 10.1161/JAHA.120.017240. Epub 2020 Aug 20.
3
Caval Penetration by Inferior Vena Cava Filters: A Systematic Literature Review of Clinical Significance and Management.下腔静脉滤器致腔静脉穿透:临床意义与处理的系统文献回顾。
Circulation. 2015 Sep 8;132(10):944-52. doi: 10.1161/CIRCULATIONAHA.115.016468. Epub 2015 Jul 13.
4
Vena cava filter practices of a regional vascular surgery society.一个地区血管外科学会的腔静脉滤器应用情况
Ann Vasc Surg. 2012 Jul;26(5):630-5. doi: 10.1016/j.avsg.2011.11.033.
5
Reporting the impact of inferior vena cava perforation by filters.报告滤器导致下腔静脉穿孔的影响。
Phlebology. 2014 Aug;29(7):471-5. doi: 10.1177/0268355513491723. Epub 2013 May 28.
6
The use of retrievable inferior vena cava filters in orthopaedic patients.可回收下腔静脉滤器在骨科患者中的应用。
J Bone Joint Surg Br. 2008 May;90(5):662-7. doi: 10.1302/0301-620X.90B5.19743.
7
Removal of retrievable inferior vena cava filters with computed tomography findings indicating tenting or penetration of the inferior vena cava wall.对于计算机断层扫描(CT)结果提示下腔静脉滤器tent(帆状)或 penetration(穿透)下腔静脉壁的患者,可采用下腔静脉滤器取出术。
J Vasc Interv Radiol. 2011 Jan;22(1):70-4. doi: 10.1016/j.jvir.2010.09.021. Epub 2010 Nov 24.
8
Anticoagulation Is Associated with Decreased Inferior Vena Cava Filter-Related Complications in Patients with Metastatic Carcinoma.抗凝治疗与转移性癌患者下腔静脉滤器相关并发症的减少有关。
Am J Med. 2017 Jan;130(1):77-82.e1. doi: 10.1016/j.amjmed.2016.06.048. Epub 2016 Jul 29.
9
Outcomes and associated factors in malpractice litigation involving inferior vena cava filters.下腔静脉滤器相关医疗事故诉讼的结果及相关因素
J Vasc Surg Venous Lymphat Disord. 2018 Jul;6(4):541-544. doi: 10.1016/j.jvsv.2018.01.016.
10
Prophylactic inferior vena cava filters in trauma patients at high risk: follow-up examination and risk/benefit assessment.高危创伤患者预防性下腔静脉滤器:随访检查及风险/效益评估
J Vasc Surg. 1999 Sep;30(3):484-88. doi: 10.1016/s0741-5214(99)70075-3.

引用本文的文献

1
A nomogram model to predict non-retrieval of short-term retrievable inferior vena cava filters.一种预测短期可回收下腔静脉滤器无法取出的列线图模型。
Front Cardiovasc Med. 2024 Dec 6;11:1393410. doi: 10.3389/fcvm.2024.1393410. eCollection 2024.
2
Efficacy and safety of a novel vena cava filter on pulmonary embolism prophylaxis: a prospective, multicenter, randomized, parallel, positive-controlled, noninferiority clinical trial.一种新型腔静脉滤器预防肺栓塞的有效性和安全性:一项前瞻性、多中心、随机、平行、阳性对照、非劣效性临床试验。
Quant Imaging Med Surg. 2024 Oct 1;14(10):7073-7085. doi: 10.21037/qims-24-879. Epub 2024 Sep 14.
3
Evaluation of hemodynamic effects of different inferior vena cava filter heads using computational fluid dynamics.
使用计算流体动力学评估不同下腔静脉滤器头部的血流动力学效应。
Front Bioeng Biotechnol. 2022 Oct 10;10:1034120. doi: 10.3389/fbioe.2022.1034120. eCollection 2022.
4
Ibero-American Society of Interventionism (SIDI) and the Spanish Society of Vascular and Interventional Radiology (SERVEI) Standard of Practice (SOP) for the Management of Inferior Vena Cava Filters in the Treatment of Acute Venous Thromboembolism.伊比利亚美洲介入治疗学会(SIDI)和西班牙血管与介入放射学会(SERVEI)关于急性静脉血栓栓塞治疗中下肢静脉腔静脉滤器管理的实践标准(SOP)
J Clin Med. 2021 Dec 24;11(1):77. doi: 10.3390/jcm11010077.
5
Efficacy and safety of rivaroxaban in patients with inferior vena cava filter placement without anticoagulation contraindications (EPICT): a prospective randomised controlled trial study protocol.利伐沙班在无抗凝禁忌的下腔静脉滤器置入患者中的疗效和安全性(EPICT):一项前瞻性随机对照试验研究方案。
BMJ Open. 2021 Oct 25;11(10):e045530. doi: 10.1136/bmjopen-2020-045530.